Emerging evidence has demonstrated that radiotherapy (RT) can not only cause direct
damage to cancer cells but also lead to immunogenic cell death (ICD), which involves the …

Cancer stem cells (CSCs) with their self-renewal ability are accepted as cells which initiate
tumors. CSCs are regarded as interesting targets for novel anticancer therapeutic agents …

Bismuth-containing nanoparticles (BNPs) are potential enhancers for tumor radiotherapy.
Improving the bioavailability and developing synergistic therapeutic regimens benefit the …

Approximately 30 years ago, endoglin was identified as a transforming growth factor (TGF)-β
coreceptor with a crucial role in developmental biology and tumor angiogenesis. Its …

The liver is perfused by both arterial and venous blood, with a resulting abnormal
microenvironment selecting for more-aggressive malignancies. Hepatocellular carcinoma …

Prostate cancer (PCa) remains a critical global health challenge, with high mortality rates
and significant heterogeneity, particularly in advanced stages. While early-stage PCa is …

A spotlight has been shone on endoglin in recent years due to that fact of its potential to
serve as both a reliable disease biomarker and a therapeutic target. Indeed, endoglin has …

Cancer is one of the diseases with the highest morbidity and mortality rates worldwide, and
its therapeutic options are inadequate. The endothelial glycoprotein, also known as CD105 …

Simple Summary Tumor cells from the same specimen are functionally heterogeneous.
Cancer stem cells (CSCs) are populations of tumor cells with self-renewal and differentiation …

Resistance to anticancer drugs limits the effectiveness of chemotherapy in cancers.
Melanoma cell lines B16F10C and A375C (parental) and B16F10R and A375R (drug …